Function
Locations
Couples oxidation of glyceraldehyde-3-phosphate to formation of the high-energy acyl-phosphate 1,3-bisphosphoglycerate and reduction of NAD+ to NADH (reviewed previously; also a well-known moonlighting protein).
The payoff (energy-yielding) phase of glycolysis is the second half of the cytosolic pathway, converting each glyceraldehyde-3-phosphate produced in the investment phase into pyruvate while generating ATP and NADH. Five steps: glyceraldehyde-3-phosphate dehydrogenase (GAPDH) oxidises and phosphorylates glyceraldehyde-3-phosphate to 1,3-bisphosphoglycerate, reducing NAD+ to NADH; phosphoglycerate kinase (PGK1) transfers a phosphate from 1,3-bisphosphoglycerate to ADP, forming 3-phosphoglycerate and the first ATP (substrate-level phosphorylation); phosphoglycerate mutase (muscle PGAM2) isomerises 3-phosphoglycerate to 2-phosphoglycerate; enolase (muscle ENO3) dehydrates 2-phosphoglycerate to phosphoenolpyruvate; and pyruvate kinase (liver/RBC PKLR, or muscle/other PKM) transfers the phosphate of phosphoenolpyruvate to ADP, forming pyruvate and the second ATP. Per glucose (two trioses) the payoff phase yields 4 ATP and 2 NADH, for a net glycolytic gain of 2 ATP + 2 NADH + 2 pyruvate. Because mature erythrocytes rely entirely on glycolytic ATP, defects here characteristically cause hereditary nonspherocytic hemolytic anemia, often combined with tissue-specific features: PGK1 deficiency (X-linked hemolytic anemia + myopathy + CNS disease); PGAM2 deficiency = glycogen storage disease type X (muscle); ENO3 deficiency = GSD type XIII (muscle); and PKLR deficiency = pyruvate kinase deficiency, the commonest glycolytic cause of hemolytic anemia.
All recommended fields populated.
✗ none found
No MODULE:glycolysis_payoff_phase deep-research report alongside the module YAML.
✓ every leaf node grounds to a representative protein.
✓ every declared conforms_to bundle matches its template motif.
6 gene-function check(s) reflected in core functions · 0 conflict(s) · 1 evidence or coverage gap(s) (11 comparison(s))
Retained noncore functions are reported separately; they do not require promotion to core functions. Support from representative genes does not establish conservation across the whole family. Missing reviews or identifiers leave a claim unverified.
| Annoton | Participant | Function | Assessment |
|---|---|---|---|
| gapdh_activity | GAPDH (human) UniProtKB:P04406 Family Representative |
glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity GO:0004365 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| pgk_activity | PGK1 (human, somatic) UniProtKB:P00558 Family Representative |
phosphoglycerate kinase activity GO:0004618 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| pgam_activity | PGAM2 (human, muscle isozyme) UniProtKB:P15259 Family Representative |
phosphoglycerate mutase activity GO:0004619 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| enolase_activity | ENO3 (human, muscle beta-enolase) UniProtKB:P13929 Family Representative |
phosphopyruvate hydratase activity GO:0004634 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| pk_activity | PKLR (human, liver/red-cell isozyme) UniProtKB:P30613 Family Representative |
pyruvate kinase activity GO:0004743 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| pk_activity | PKM (human, muscle/M1-M2 isozyme) UniProtKB:P14618 Family Representative |
pyruvate kinase activity GO:0004743 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| gapdh_activity | Glyceraldehyde-3-phosphate dehydrogenase family (GAPDH/GAPDHS) PANTHER:PTHR10836 Family |
glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity GO:0004365 |
Family Supported
Family review supports GO:0004365 FAMILY_WIDE. Asserted by emp_glycolysis, gluconeogenesis and glycolysis_payoff_phase; accepted by the S. cerevisiae, S. pombe, human and mouse reviews. |
| pgk_activity | Phosphoglycerate kinase family (PGK1/PGK2) PANTHER:PTHR11406 Family |
phosphoglycerate kinase activity GO:0004618 |
Family Supported
Family review supports GO:0004618 FAMILY_WIDE. Asserted by emp_glycolysis, gluconeogenesis and glycolysis_payoff_phase; accepted by S. cerevisiae PGK1, S. pombe pgk1, human PGK1 and P. putida Pgk. |
| pgam_activity | Cofactor-dependent phosphoglycerate mutase family (PGAM1/PGAM2/BPGM) PANTHER:PTHR11931 Family |
phosphoglycerate mutase activity GO:0004619 |
Family Scope Restricted
GO:0004619 is SUBFAMILY_ONLY; this family grounding does not establish the allowed subfamily scope. The active PGM subfamilies. The emp_glycolysis, gluconeogenesis and glycolysis_payoff_phase modules select the base family, which also takes in BPGM and GPM2/GPM3. SF11 (BPGM) is listed because BPGM has a genuine minor phosphoglycerate mutase activity (EC 5.4.2.11), kept as non-core in its review. |
| enolase_activity | Enolase family (ENO1/ENO2/ENO3) PANTHER:PTHR11902 Family |
phosphopyruvate hydratase activity GO:0004634 |
Family Supported
Family review supports GO:0004634 FAMILY_WIDE. The modules (emp_glycolysis, gluconeogenesis, glycolysis_payoff_phase) select the whole family for this activity, and PAINT puts it at the family root. Experimental seeds cover every major lineage and include yeast ERR2 and ERR3. ERR1 and ENO4 hold the activity by homology only. For ERR1 the active-site residues are intact, so neither is treated as an exception. |
| pk_activity | Pyruvate kinase family (PKM/PKLR) PANTHER:PTHR11817 Family |
pyruvate kinase activity GO:0004743 |
Family Supported
Family review supports GO:0004743 FAMILY_WIDE. All modules that use the family (emp_glycolysis, glycolysis_payoff_phase, bacterial_pyruvate_metabolism) select the base family for this activity. That is safe for every characterized member. The only known loss is the Drosophila SF3 paralog set, which PAINT already excludes by IKR, so module selectors that rely on IBA inherit the correct exclusion. A module that selects SF3 or the family by sequence alone would include those paralogs. |
6 complete review(s) · 2 with deep research · 0 missing review · 4 reviewed but lacking deep research
| Gene | Review | Complete | Deep research |
|---|---|---|---|
| ENO3 P13929 | ✓ | ✓ | ✗ |
| GAPDH P04406 | ✓ | ✓ | ✓ |
| PGAM2 P15259 | ✓ | ✓ | ✗ |
| PGK1 P00558 | ✓ | ✓ | ✗ |
| PKLR P30613 | ✓ | ✓ | ✗ |
| PKM P14618 | ✓ | ✓ | ✓ |
Five-step payoff phase of glycolysis grounded to the human enzymes GAPDH (UniProtKB:P04406, GO:0004365), phosphoglycerate kinase PGK1 (P00558, GO:0004618), phosphoglycerate mutase PGAM2 (P15259, GO:0004619), beta-enolase ENO3 (P13929, GO:0004634) and pyruvate kinase PKLR (P30613) / PKM (P14618) (GO:0004743). GO molecular-function terms were taken from the human GOA records; Reactome reaction ids and titles were verified against the local reactome cache. Each step uses a PANTHER family selector generic over the tissue isozymes and orthologs (PGAM node covers PGAM1/PGAM2/BPGM; enolase node ENO1/ENO2/ENO3; pyruvate-kinase node PKLR + PKM). GAPDH and PKM were reviewed previously (already on main) and are cross-linked via file: evidence; PGK1/PGAM2/ENO3/PKLR are the reviews new in this batch. Upstream, the two glyceraldehyde-3-phosphate molecules come from the glycolysis investment phase (hexokinase -> GPI -> PFK -> aldolase -> TPI); downstream, pyruvate feeds the pyruvate-metabolism module (PDC/PC) and lactate fermentation (LDHA/LDHB, a separate module), while the reverse reactions (except the PFK/PK/hexokinase committed steps) serve gluconeogenesis. Moonlighting roles (GAPDH; PGK1 extracellular reductase; PKM2 nuclear/protein-kinase) are captured non-core in the individual gene reviews. Disorders: PGK1 (X-linked hemolytic anemia + myopathy + CNS); PGAM2 (GSD X); ENO3 (GSD XIII); PKLR (pyruvate kinase deficiency, hemolytic anemia).
Couples oxidation of glyceraldehyde-3-phosphate to formation of the high-energy acyl-phosphate 1,3-bisphosphoglycerate and reduction of NAD+ to NADH (reviewed previously; also a well-known moonlighting protein).
Generates the first ATP of glycolysis by substrate-level phosphorylation (reverse direction in gluconeogenesis). X-linked PGK1 deficiency causes hemolytic anemia with myopathy and CNS disease; PGK2 is testis-specific.
Interconverts 3- and 2-phosphoglycerate (dimer of the muscle PGAM2/M and brain PGAM1/B subunits; muscle = PGAM2 homodimer). PGAM2 deficiency = GSD type X (exercise intolerance, myoglobinuria).
Mg2+-dependent dehydration of 2-phosphoglycerate to phosphoenolpyruvate. Tissue isozymes ENO1 (alpha, ubiquitous), ENO2 (gamma, neuronal), ENO3 (beta, muscle); ENO3 deficiency = GSD type XIII.
Final, essentially irreversible glycolytic step generating the second ATP; homotetramer, Mg2+/K+-dependent, allosterically activated by fructose-1,6-bisphosphate. PKLR (liver/RBC) deficiency = pyruvate kinase deficiency (commonest glycolytic hemolytic anemia); PKM = muscle/other.